An additional one (1) DuoDote lot is no longer useable and should be properly disposed of. FDA is alerting civilian health care professionals and emergency responders of one (1) pralidoxime chloride and five (5) CANA (diazepam) auto-injector lots for which the “new use date” has passed however, FDA recommends that stakeholders retain such lots in the event that additional scientific information becomes available to support additional extensions.
Please refer to the table below for such updates.įor questions about DuoDote orders, stakeholders should contact Jonathan Daproza at Meridian Medical Technologies at ( 44 ) or MMT’s main email address ( or phone number ( 44 ). An additional six (6) DuoDote lots are no longer useable and should be properly disposed of. Please refer to the posting and table below for instructions about the usability of certain DuoDote, AtroPen (atropine), and morphine sulfate lots. CANA (diazepam) and Pralidoxime Chloride auto-injectors manufactured by Meridian Medical Technologies nearing or beyond their labeled or extended expiration dates should be retained until further guidance is provided by FDA.
0 kommentar(er)
